New point of attack against stomach bacterium Helicobacter pylori

New point of attack against stomach bacterium Helicobacter pylori
Helicobacter pylori uses a special enzyme to synthesize vitamin K2, posing a potential point of attack for new medications. Neutron scattering of a crystal of this enzyme revealed a detailed picture of the positions and position changes of the hydrogen atoms in the catalytical process. Credit: Andreas Ostermann / TUM

There is a strong suspicion that Helicobacter pylori is linked to the development of stomach cancer. Now an international team of researchers led by Prof. Donald R. Ronning (University of Toledo) has used neutrons to unlock the secret to the functionality of an important enzyme in the bacterium's metabolism. This could be used as a point of attack for new medications. The team made the corresponding measurements at the neutron sources in Oak Ridge and at the research neutron source FRM II of the Technical University of Munich (TUM).

One in every two people everywhere in the world has it in his or her stomach: Helicobacter pylori. Ulcers and chronic gastritis are the most common illnesses associated with this bacterium. Up to now the standard therapy used to combat this stomach germ has been a combination of two antibiotics and a . But this treatment is only successful in 70 percent of cases, and an increasing level of resistance is developing. For quite some time now scientists have therefore been searching for alternative medications to fight this dangerous bacterium.

In contrast to humans and to many helpful bacteria, H. pylori uses a special to synthesize vitamin K2. As a result, this enzyme, 5'-methylthioadenosine nucleosidase (MTAN), offers very promising prospects for the development of a medication that acts specifically against H. pylori without harming useful bacteria or even human cells.

Structural determination with neutrons

The enzyme MTAN is part of an important step in the synthesis of vitamin K2. Hydrogen bonds bind a precursor of the vitamin in order to cut off a side chain. But the positions and position changes of the essential to this process were not previously known with certainty.

New point of attack against stomach bacterium Helicobacter pylori
The joint measurements of hundreds of diffraction images taken at the neutron sources in Garching (Germany) and Oakridge (USA) allowed the scientists to draw a detailed picture of the MTAN-enzyme's mode of action. Credit: Andreas Ostermann / TUM

The usual method of structural determination for enzymes, crystal structure analysis using x-ray radiation, is of little help here, since the x-ray radiation is almost blind to hydrogen atoms. Therefore, the researchers based their structural determination on neutrons, which are particularly sensitive to hydrogen atoms.

The scientists investigated different variations of the enzyme at the BIODIFF diffractometer, operated jointly by the TUM and the Jülich Centre for Neutron Science (JCNS) in the Heinz Maier-Leibnitz Zentrum in Garching north of Munich, and at the Oak Ridge National Laboratory (USA) neutron source. The joint measurements allowed them draw a detailed picture of the enzyme's mode of action.

"Now that we know the exact process of the reaction and the binding sites of the enzyme involved, it's possible to develop molecules that block exactly this process," says TUM biologist Andreas Ostermann, who supervises the instrument at the FRM II together with Dr. Tobias Schrader (JCNS).

New point of attack against stomach bacterium Helicobacter pylori
Dr. Andreas Ostermann (right) and Dr. Tobias Schrader at the instrument BIODIFF of the Heinz Maier Leibnitz Zentrum in Garching. Credit: W. Schuermann / TUM

Explore further

Scientists unveil hidden step in enzyme mechanism

More information: Michael T. Banco et al, Neutron structures of the5′-methylthioadenosine nucleosidase highlight proton sharing and protonation states, Proceedings of the National Academy of Sciences (2016). DOI: 10.1073/pnas.1609718113
Citation: New point of attack against stomach bacterium Helicobacter pylori (2016, December 20) retrieved 11 May 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments